No Data
No Data
Boji Medical Technology Unit Gets Patent for Joint Pain Treatment
Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 39% Bounce
boji medical technology (300404.SZ): Wholly-owned subsidiary obtains a patent certificate for an invention.
Boji Medical Technology (300404.SZ) announced on October 8 that its wholly-owned subsidiary, Guangzhou Boji New Drug Clinical Research Center Co., Ltd., recently received an invention patent certificate issued by the National Intellectual Property Office. The invention is titled a traditional chinese medicine composition, formulation, preparation method, and application for treating joint pain. This invention belongs to the field of traditional chinese medicine preparations. Through evaluation experiments of anti-inflammatory and analgesic effects on different processed samples in mouse models, it was found that each processed sample has certain analgesic and anti-inflammatory effects, which can be used for joint pain, shoulder periarthritis, and pain caused by lumbar disc herniation. This prescription not only improves the anti-inflammatory efficacy.
Boji Medical TechnologyLtd's (SZSE:300404) Earnings Might Be Weaker Than You Think
Broge Pharmaceuticals: 2024 Semi-Annual Report Summary
Broge Pharmaceuticals: Semi-Annual Report 2024
No Data
No Data